OWC Pharmaceutical Research Corp.

Common Stock SEC Reporting - Current
Verified Company Profile 7/14/2017
Contact Info
  • 30 Shacham Street
  • P.O.B. 8324
  • Petach-Tikva 4918103
  • Israel

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001431934
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 2008
Employees 6 a/o Jun 30, 2017
Company Officers/Contacts
Mordechai Bignitz CEO, President
Alon Sinai COO
Yossi Dagan CFO
Yehuda Baruch Chief Scientific Officer, Director, R&D
Richard Rubin Counsel
Company Directors
Dr. Stanley Hirsch Chairman
Mordechai Bignitz Chairman
Service Providers
Accounting/Auditing Firm
Fahn Kanne & Co.
23 Menachem Begin St.
Levenstein Tower
24th floor
Tel-Aviv, 66184
Securities Counsel
Thomas J. Craft, Jr. Esq.
18096 SE Heritage Dr
Ste. 2102
Tequesta, FL, 33469
United States
Investor Relations Firm

Not Available
Company History
  • Formerly=Dynamic Applications Corp. until 1-2015
OWCP Security Details
Share Structure
Market Value1 $59,682,541 a/o Oct 17, 2017
Authorized Shares 500,000,000 a/o Oct 10, 2017
Outstanding Shares 146,316,600 a/o Oct 10, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 118,240,011 a/o Jun 30, 2017
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 128 a/o Jul 21, 2017
Short Selling Data
Short Interest 32,644 (279.58%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security